SmartPractice Denmark ApS
BiotechSmartPractice Denmark ApS is a biotechnology company with 2 FDA-approved products.
SmartPractice Denmark ApS's Key Drugs
SmartPractice Denmark ApS's core commercial portfolio centers on hudquzco rubber panel,rubber panel t.r.u.e. test — its most strategically important drugs approved in the last 15 years.
SmartPractice Denmark ApS's Recent FDA Approvals
New NDA/BLA approvals for SmartPractice Denmark ApS over the last two years — novel drugs only, excluding generics and label supplements.
SmartPractice Denmark ApS's Therapeutic Areas
Disease areas where SmartPractice Denmark ApS has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.
SmartPractice Denmark ApS Pipeline Snapshot
Active clinical trials for SmartPractice Denmark ApS across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • hudquzco rubber panel,rubber panel t.r.u.e. test leads revenue
- • Drug-level revenue analysis
Trial Catalysts
- • Active trial monitoring
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Discontinued (0)
Company Info
- First Approval
- 1997-08-14
- Latest
- 2017-03-02
- Applications
- 2